Barclays Lowers Estimates on DryShips (DRYS) Again; Soft Quarter and Challenging Dry Bulk
Tweet Send to a FriendGet Alerts DRYS Hot Sheet
Price: $2.09 --0%
Rating Summary:
3 Buy, 6 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 8
Rating Summary:
3 Buy, 6 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 8
Trade DRYS Now!
Barclays maintains an 'Equalweight' on DryShips (NASDAQ: DRYS) price target of $4.50.
A few days ago, analyst, Brandon R. Oglenski, cut FY12 EPS estimate from $0.32 to $0.10. However, today, Oglenski, cut FY12 EPS estimate again, from $0.10 to -0.02. Although, for FY13, he raised estimates from $0.40 to $0.50.
Oglenski felt the need to cut estimates again after saying DRYS reported a soft Q1 against low expectations. Liquidity is improving, but overall challenges in dry bulk remain.
For an analyst ratings summary and ratings history on DryShips click here. For more ratings news on DryShips click here.
Shares of DryShips closed at $2.37 yesterday, with a 52 week range of $1.75-$4.34.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
A few days ago, analyst, Brandon R. Oglenski, cut FY12 EPS estimate from $0.32 to $0.10. However, today, Oglenski, cut FY12 EPS estimate again, from $0.10 to -0.02. Although, for FY13, he raised estimates from $0.40 to $0.50.
Oglenski felt the need to cut estimates again after saying DRYS reported a soft Q1 against low expectations. Liquidity is improving, but overall challenges in dry bulk remain.
For an analyst ratings summary and ratings history on DryShips click here. For more ratings news on DryShips click here.
Shares of DryShips closed at $2.37 yesterday, with a 52 week range of $1.75-$4.34.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Benchmark Boosts PT on R.R. Donnelley (RRD)
- UPDATE: JPMorgan Cuts SodaStream (SODA) to Neutral, 'Stock No Longer Cheap'
- Wedbush Expects Positive Results from Insmed (INSM) ARIKAC Trial
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS ViewRelated Entities
Barclays
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
